Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mutant KRAS G12V-specific TCR transduced autologous T cell therapy
i
Other names:
mutant KRAS G12V-specific TCR transduced autologous T cell therapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Changhai Hospital
Drug class:
KRAS G12V inhibitor
Related drugs:
‹
AFNT-211 (1)
YL-17231 (1)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
YK0901 (0)
AFNT-211 (1)
YL-17231 (1)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
YK0901 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login